Public Policy Newsletter

What’s Inside: Biocom California’s Roundtable with FDA; Energy & Ag Biotech Advocacy Fly-In; GO-Biz Income Tax Credit; Changes to COVID-19 Guidance; Mid-Coast Trolley Report; LA District 6 Special Election; San Francisco Corporate Tax Relief; and more.

What’s Inside: Biocom California Hosts Meet and Greets on Capitol Hill; FDA User Fee Infographics; COVID-19 Emergency Ending; Comment Opportunities; California Drought Conditions; San Diego Land Development Code Update; LA Homeless Initiatives;
San Carlos Ban on BSL 3 Labs; and more.

What’s Inside: Biocom California Public Policy Recaps 2022; Applications Open for $120M in Budget Tax Credits; State Budget Figures Unveiled; and more.

What’s Inside: Midterm Election Results; Inflation Reduction Act; California’s Potential $24 Billion Deficit; and more.

What’s Inside: Recap of Our Annual Roundtable with Mayor Todd Gloria; A Commitment for 10,000 New Affordable Homes in San Diego; Hear Directly from DARPA on Funding Opportunities; Take Action on a New TRIPS IP Waiver; and more.

What’s Inside: Recap of Our Inaugural USPTO & FDA Webinar; Senate Reauthorizes SBIR/STTR; Update on California Green Building Code; San Diego Receives Landmark EPA Loan; and more.

What’s Inside: Congress Passes Drug Pricing Legislation; Update and Comparison on FDA User Fee Bills; First Female Director of NCI Appointed; Pasadena HazMat Rule Changes; and more.

What’s Inside: FDA User Fee Negotiations Ongoing; Drug Pricing Bill Introduced in Senate; Biocom California Initiates Pasadena HazMat Rule Changes; State Opens Applications for Next Round of California Competes Credits and Grants; and more.

What’s Inside: June Primary Highlights; FDA User Fee Legislation Passes House; New Bay Area Water Restrictions; San Diego County Proposes $618.7M Budget; and more.

What’s Inside: Mail-In Ballots Out for Primary Election; Biocom California Committee Meeting with USPTO’s Silicon Valley Director; State Considers Public Right to Know Act